What does net gains (losses) on investments mean?

Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.

King Pharmaceuticals KG Net gains (losses) on investments

Net gains (losses) on investments at other companies

Everest GroupEG

-$10M-42.9%

Selective Insurance GroupSIGI

-$8.3M-3,725%

W.R. BerkleyWRB

$33.06M+12.3%

Universal Insurance HoldingsUVE

-$294.25K-112%

Silvercrest Asset Management GroupSAMG

-$79K—

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnInvestments.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's net gains (losses) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's net gains (losses) on investments?: King Pharmaceuticals (KG) reported net gains (losses) on investments of $1.34M in Q1 2026.
What does net gains (losses) on investments mean?: Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.